Johnson & Johnson Income Taxes 2010-2024 | JNJ
Johnson & Johnson annual/quarterly income taxes history and growth rate from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
- Johnson & Johnson income taxes for the quarter ending September 30, 2024 were $0.644B, a 29.07% decline year-over-year.
- Johnson & Johnson income taxes for the twelve months ending September 30, 2024 were $2.859B, a 99.93% increase year-over-year.
- Johnson & Johnson annual income taxes for 2023 were $1.736B, a 41.92% decline from 2022.
- Johnson & Johnson annual income taxes for 2022 were $2.989B, a 117.07% increase from 2021.
- Johnson & Johnson annual income taxes for 2021 were $1.377B, a 22.77% decline from 2020.
Johnson & Johnson Annual Income Taxes
(Millions of US $) |
| 2023 |
$1,736 |
| 2022 |
$2,989 |
| 2021 |
$1,377 |
| 2020 |
$1,783 |
| 2019 |
$2,209 |
| 2018 |
$2,702 |
| 2017 |
$16,373 |
| 2016 |
$3,263 |
| 2015 |
$3,787 |
| 2014 |
$4,240 |
| 2013 |
$1,640 |
| 2012 |
$3,261 |
| 2011 |
$2,689 |
| 2010 |
$3,613 |
| 2009 |
$3,489 |
Johnson & Johnson Quarterly Income Taxes
(Millions of US $) |
| 2024-09-30 |
$644 |
| 2024-06-30 |
$1,062 |
| 2024-03-31 |
$459 |
| 2023-12-31 |
$694 |
| 2023-09-30 |
$908 |
| 2023-06-30 |
$930 |
| 2023-03-31 |
$-796 |
| 2022-12-31 |
$388 |
| 2022-09-30 |
$862 |
| 2022-06-30 |
$1,026 |
| 2022-03-31 |
$713 |
| 2021-12-31 |
$-421 |
| 2021-09-30 |
$182 |
| 2021-06-30 |
$384 |
| 2021-03-31 |
$1,232 |
| 2020-12-31 |
$-91 |
| 2020-09-30 |
$847 |
| 2020-06-30 |
$314 |
| 2020-03-31 |
$713 |
| 2019-12-31 |
$208 |
| 2019-09-30 |
$-106 |
| 2019-06-30 |
$1,434 |
| 2019-03-31 |
$673 |
| 2018-12-31 |
$80 |
| 2018-09-30 |
$489 |
| 2018-06-30 |
$1,019 |
| 2018-03-31 |
$1,114 |
| 2017-12-31 |
$13,273 |
| 2017-09-30 |
$1,026 |
| 2017-06-30 |
$921 |
| 2017-03-31 |
$1,153 |
| 2016-12-31 |
$510 |
| 2016-09-30 |
$1,009 |
| 2016-06-30 |
$907 |
| 2016-03-31 |
$837 |
| 2015-12-31 |
$543 |
| 2015-09-30 |
$764 |
| 2015-06-30 |
$1,225 |
| 2015-03-31 |
$1,255 |
| 2014-12-31 |
$182 |
| 2014-09-30 |
$2,061 |
| 2014-06-30 |
$1,300 |
| 2014-03-31 |
$697 |
| 2013-12-31 |
$-769 |
| 2013-09-30 |
$685 |
| 2013-06-30 |
$960 |
| 2013-03-31 |
$764 |
| 2012-12-31 |
$533 |
| 2012-09-30 |
$966 |
| 2012-06-30 |
$627 |
| 2012-03-31 |
$1,135 |
| 2011-12-31 |
$100 |
| 2011-09-30 |
$909 |
| 2011-06-30 |
$646 |
| 2011-03-31 |
$1,034 |
| 2010-12-31 |
$286 |
| 2010-09-30 |
$802 |
| 2010-06-30 |
$771 |
| 2010-03-31 |
$1,754 |
| 2009-12-31 |
$398 |
| 2009-09-30 |
$900 |
| 2009-06-30 |
$1,055 |
| 2009-03-31 |
$1,136 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$351.152B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
